Funder: Wellcome Trust
Due Dates: June 2, 2026
Funding Amounts: £1,000,000–£8,000,000 per award | 3–5 years duration | 8–12 awards expected
Summary: Funds transdisciplinary teams led from Africa, South Asia, or South-East Asia to run high-impact clinical trials optimising licensed pharmaceutical interventions for infectious diseases in low- and middle-income countries.
Key Information: Lead applicant must be based in an eligible African, South Asian, or South-East Asian country (excluding mainland China).